(Press-News.org) Researchers at Emory University School of Medicine have identified a new type of potential anticancer drug. The compound, named FOBISIN, targets 14-3-3 proteins, important for the runaway growth of cancer cells.
The researchers were using X-rays to see how FOBISIN fits into the clamp-shaped 14-3-3 protein structure. Unexpectedly, the X-rays induced the compound to be permanently bonded to the protein. The finding suggests that compounds like FOBISIN can be used in combination with radiation to trigger potent anticancer activity.
The results were published online Sept. 9 in Proceedings of the National Academy of Sciences Early Edition.
Senior author Haian Fu, PhD, has been studying 14-3-3 proteins for two decades. He is professor of pharmacology and of hematology and oncology at Emory University School of Medicine, and the director of the Emory Chemical Biology Discovery Center.
"Targeting 14-3-3 proteins could be especially valuable because they can impact multiple pathways critical for cancer cell growth," he says. "14-3-3 proteins have been shown to be dysregulated in a number of cancer types, including lung cancer and breast cancer."
14-3-3 proteins act as adaptors that clamp onto other proteins. Fu and co-workers Jing Zhao, PhD,postdoctoral fellow, and Yuhong Du, PhD, assistant professor and associate director of the Discovery Center, sorted through thousands of chemicals to find one (FOBISIN: Fourteen-three-three Binding Small molecule Inhibitor) that prevents 14-3-3 from interacting with its partners.
14-3-3 proteins are found in mammals, plants and fungi. In humans, they come in seven varieties, and FOBISIN appears to inhibit interactions by all seven.
A 14-3-3 proteins' ability to clamp depends on whether the target protein is phosphorylated, a chemical modification that regulates protein function. FOBISIN's inhibitory power also requires the presence of phosphorylation in the molecule.
Fu's group teamed up with the laboratory of Xiaodong Cheng, PhD, co-senior author, professor of biochemistry and a Georgia Research Alliance Eminent Scholar, to examine how FOBISIN fits into its targets.
Scientists use X-rays as a tool to probe protein structure. If a protein and a drug that targets it can be crystallized together, the X-ray diffraction pattern from the crystals reveals the 3D arrangement of the atoms and how the drug interacts with the protein. Research assistant professor John Horton, PhD, and research associate Anup Upadhyay, PhD, in the Cheng laboratory used synchrotron X-ray radiation from the Advanced Photon Source at Argonne National Laboratory for this purpose.
"In this case, the X-rays had an unexpected effect: they caused FOBISIN to become covalently attached to the 14-3-3 protein," Cheng says.
The finding suggests that compounds like FOBISIN could be developed as "pro-drugs" that upon exposure to radiation, permanently stick to and inhibit their targets. A common strategy in fighting cancer is to combine drugs and radiation so that the drugs increase cells' sensitivity to radiation. Here, the radiation would activate the drug.
"These compounds could be used in combination with other strategies to enhance the tumor selectivity of the treatment," Fu says.
INFORMATION:
The research was funded by the U.S. National Institutes of Health, the Georgia Cancer Coalition, and the Georgia Research Alliance.
Reference: J. Zhao, Y. Du, J.R. Horton, A.K. Upadhyay, B. Lou, Y. Bai, X. Zhang, L. Du, M. Li, B. Wang, L. Zhang, J.T. Barbieri, F.R. Khuri, X. Cheng and H. Fu. Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor. PNAS Early Edition (2011).
Writer: Quinn Eastman
END
A new study by researchers at the Johns Hopkins Center for Injury Research and Policy finds that helicopters that service the drilling platforms and vessels in the Gulf of Mexico crash on average more than six times per year resulting in an average of 5 deaths per year. From 1983 to 2009, 178 crashes resulted in 139 deaths, including 41 pilots and 3 co-pilots. Mechanical failure was the most common cause, leading to 68 crashes (38 percent of the total), followed by bad weather (16 percent of the total). While the challenges such as bad weather and long travel distances ...
Berkeley — Neuroscientists at the University of California, Berkeley, are offering hope to the 10 percent of the population who suffer from tinnitus – a constant, often high-pitched ringing or buzzing in the ears that can be annoying and even maddening, and has no cure.
Their new findings, published online last week in the journal Proceedings of the National Academy of Sciences, suggest several new approaches to treatment, including retraining the brain, and new avenues for developing drugs to suppress the ringing.
"This work is the most clearheaded documentation to ...
WINSTON-SALEM, N.C. – September 12, 2011 – A year after hospital discharge, the majority of stroke patients are listening to doctor's orders when it comes to taking their prescribed secondary stroke prevention medications, new data out of Wake Forest Baptist Medical Center shows. However, there is room for improvement, according to investigators.
"Medication non-compliance is a major risk factor for stroke and heart disease, and we know that non-compliance with stroke prevention medications increases over the year or two after a stroke," said Cheryl D. Bushnell, M.D., ...
LA JOLLA, CA - Oncologists have long sought a powerful "magic bullet" that can find tumors wherever they hide in the body so that they can be imaged and then destroyed. Until recently scientists accepted the notion that such an agent, an agonist, needed to enter and accumulate in the cancerous cells to act. An international research team has now shown in cancer patients that an investigational agent that sticks onto the surface of tumor cells without triggering internalization, an antagonist, may be safer and even more effective than agonists.
One of the Salk Institute's ...
DFW Elite Toy Museum is dog-friendly and we want all dog lovers to hold their clubs' social and fundraising events for breed rescue here at the museum. At DFW Elite Toy Museum, we know it's a dog's life.
Forth Worth entrepreneur and museum owner Ron Sturgeon is active in King Charles Cavalier spaniel rescue and recently hosted a social event at the antique toy museum for the Dallas-Fort Worth King Charles Cavalier Spaniel Club.
Members were encouraged to bring their fur-kids and enjoy the museum and a presentation by Kristy Remo of Kristy's Pampered Paws Mobile Pet ...
CLEMSON, S.C. — Celebrating the end to a successful peach season, Clemson University peach specialist Desmond Layne announced the naming of a new peach cultivar — CaroTiger. The fourth in the "Caro" — for South Carolina — series, this late-season peach will be available to growers in January 2013.
"Up until now, this peach just had a number — SC82035-13-48 — but it earned a name during our long-term germplasm evaluation research," said Layne. "We've been testing this particular selection at multiple locations for several years. Its performance has been excellent. The ...
COLUMBIA, Mo. –University of Missouri researchers have found evidence that shows those who quit smoking show improvements in their overall personality.
"The data indicate that for some young adults smoking is impulsive," said Andrew Littlefield, a doctoral student in the Department of Psychology in the College of Arts and Science. "That means that 18-year-olds are acting without a lot of forethought and favor immediate rewards over long term negative consequences. They might say, 'I know smoking is bad for me, but I'm going to do it anyway.' However, we find individuals ...
With more and more Americans upgrading to smartphones, and as smartphone capabilities continue to improve, even the U.S. government is considering innovative ways to harness this advancing technology. Human factors/ergonomics researchers have evaluated the potential benefits of using smartphones to enable online voting in future U.S. elections and will present their findings at the upcoming HFES 55th Annual Meeting in Las Vegas, Nevada.
The 2000 presidential election debacle in Florida became a national embarrassment, prompting many U.S. election officials to opt for ...
Boston, MA - Researchers at Brigham and Women's Hospital (BWH) have identified a new combination of targeted therapies that, together, may treat two aggressive tumor types that until now have not had effective treatments. These findings are published in Cancer Cell on September 13, 2011.
While numerous anti-cancer drugs are being developed, many tumors do not respond to currently available single therapies. As such, there is a major push to identify new drug combinations that can work together to treat these resistant cancers . The drug combination identified by BWH ...
Using barley as the raw material for ethanol production results in an additional product – dried grains for animal feed. But the presence of a fungal pathogen sometimes found in barley can result in a lethal toxin, called mycotoxin, in the animal feed. Now, Virginia Tech and Agricultural Research Service, USDA researchers have shown that newly developed transgenic yeast used during fermentation will help modify the mycotoxin in the animal feed product to a less toxic form. The research is published online in the September issue of Biotechnology for Biofuels.
New varieties ...
